« Return to News | Study Conduct | Technology Solutions

Partnership Assists Patient Recruitment

Tuesday, July 20, 2010 09:01 AM

Healthcare software company Bio-Optronics and Clinical Research Associates (CRA) have developed a strategic relationship to provide a solution for a clinical research site’s patient recruitment needs, which couples Bio-Optronics’ Clinical Conductor Clinical Trial Management System (CTMS) and Clinical Research Associates’ patient recruitment offerings. Clinical Conductor CTMS is an enterprise workflow system for organizing the daily activities involving clinical research. Users can automate their regular routine to track the necessary metrics to maintain a viable research business, create efficiencies to take on more research with the same personnel, negotiate contracts, and efficiently recruit patients. “More sites have been proactively coming to us looking for ways to recruit faster, run trials more effectively, reduce costs, and be more marketable to sponsors,” Bio-Optronics Vice President Maria Durkin said. Clinical Conductor allows sites to leverage data about protocols and patients and provides the ability to quickly identify potential study subjects within an existing patient database. CRA specializes in patient recruitment and appointment scheduling for the clinical research industry.

 

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.